Education
About Us
Working with TipRanks
Follow Us
Pfizer (DE:PFE)
XETRA:PFE
Total Valuation
Pfizer has a market cap or net worth of $121.96B. The enterprise value is €186.89B.
Market Cap$121.96B
Enterprise Value€186.89B
Share Statistics
Pfizer has 5,685,550,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,685,550,300
Owned by Insiders0.03%
Owned by Institutions1.29%
Financial Efficiency
Pfizer’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 9.33%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)9.33%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee785.52K
Profits Per Employee99.40K
Employee Count81,000
Asset Turnover0.30
Inventory Turnover2.01
Valuation Ratios
The current PE Ratio of Pfizer is 12.5. Pfizer’s PEG ratio is ―.
PE Ratio12.5
PS Ratio―
PB Ratio―
Price to Fair Value1.70
Price to FCF―
Price to Operating Cash Flow9.42
PEG Ratio―
Income Statement
In the last 12 months, Pfizer had revenue of 63.63B and earned 8.02B in profits. Earnings per share was 1.42.
Revenue63.63B
Gross Profit41.85B
Operating Income16.48B
Pretax Income8.02B
Net Income8.02B
EBITDA18.13B
Earnings Per Share (EPS)1.42
Cash Flow
In the last 12 months, operating cash flow was 15.19B and capital expenditures -2.75B, giving a free cash flow of 12.44B billion.
Operating Cash Flow15.19B
Free Cash Flow12.44B
Free Cash Flow per Share2.19
Dividends & Yields
Pfizer pays an annual dividend of €0.367, resulting in a dividend yield of 6.83%
Dividend Per Share€0.367
Dividend Yield6.83%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change-12.01%
50-Day Moving Average20.91
200-Day Moving Average22.15
Relative Strength Index (RSI)57.01
Average Volume (3m)48.45K
Important Dates
Pfizer upcoming earnings date is Nov 4, 2025, Before Open (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 4, 2025
Ex-Dividend DateJul 25, 2025
Financial Position
Pfizer as a current ratio of 1.17, with Debt / Equity ratio of 69.67%
Current Ratio1.17
Quick Ratio0.92
Debt to Market Cap0.42
Net Debt to EBITDA3.45
Interest Coverage Ratio5.33
Taxes
In the past 12 months, Pfizer has paid -28.00M in taxes.
Income Tax-28.00M
Effective Tax Rate>-0.01
Enterprise Valuation
Pfizer EV to EBITDA ratio is 11.74, with an EV/FCF ratio of 21.64.
EV to Sales3.35
EV to EBITDA11.74
EV to Free Cash Flow21.64
EV to Operating Cash Flow16.70
Balance Sheet
Pfizer has $13.25B in cash and marketable securities with $61.80B in debt, giving a net cash position of $48.55B billion.
Cash & Marketable Securities$13.25B
Total Debt$61.80B
Net Cash$48.55B
Net Cash Per Share$8.54
Tangible Book Value Per Share-$6.26
Margins
Gross margin is 67.34%, with operating margin of 25.91%, and net profit margin of 12.60%.
Gross Margin67.34%
Operating Margin25.91%
Pretax Margin12.61%
Net Profit Margin12.60%
EBITDA Margin28.49%
EBIT Margin17.47%
Analyst Forecast
The average price target for Pfizer is $24.42, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$24.42
Price Target Upside14.02% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast―
EPS Growth Forecast―